CPT code 91200 captures elastography-based imaging used to evaluate liver lesions by measuring tissue elasticity to distinguish benign from malignant tumors and differentiate lesions from normal parenchyma. Nationally, utilization of elastography is important as noninvasive lesion characterization can reduce unnecessary biopsies and guide follow-up imaging or treatment planning.

This analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for CPT code 91200, common sites of service and service type, and what payers typically consider when reimbursing elastography procedures. The publication provides benchmarking context where available, describes coding and billing considerations, and outlines policy and coverage themes relevant to diagnostic liver elastography.

Intended for clinical administrators, coding professionals, and policy analysts, the summary highlights where elastography fits into diagnostic pathways for liver lesions and which payer policies and reimbursement practices influence access to this noninvasive imaging option. Data not available in the input is noted where applicable.